Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 373 entries
View as:

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe

Phase: N/A Priority: Normal
NCT ID: NCT03547271 Org: User:
Start: 12/14/18 End: 05/24/23 Due: 05/24/24

Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00383526 Org: User:
Start: 09/30/06 End: 09/30/09 Due: 09/30/10

Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02752906 Org: User:
Start: 04/15/16 End: 12/19/16 Due: 12/19/17

A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center Study

Phase: N/A Priority: Normal
NCT ID: NCT06165276 Org: User:
Start: 07/25/06 End: 08/27/08 Due: 08/27/09

Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT01967784 Org: User:
Start: 10/31/13 End: 07/31/14 Due: 07/31/15

Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT06507553 Org: User:
Start: 08/12/24 End: 03/04/25 Due: 03/04/26

Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT01481454 Org: User:
Start: 03/31/12 End: 12/31/12 Due: 12/31/13

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Phase: N/A Priority: Normal
NCT ID: NCT02993757 Org: User:
Start: 12/01/16 End: 05/27/19 Due: 05/27/20

Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT04537208 Org: User:
Start: 09/03/20 End: 11/19/21 Due: 11/19/22

A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00343681 Org: User:
Start: 07/31/06 End: 08/31/07 Due: 08/31/08

Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00623181 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster Dose

Phase: N/A Priority: Normal
NCT ID: NCT00483470 Org: User:
Start: 06/30/07 End: 08/31/08 Due: 08/31/09

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.

Phase: N/A Priority: Normal
NCT ID: NCT00390884 Org: User:
Start: 10/31/06 End: 09/30/08 Due: 09/30/09

Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years

Phase: N/A Priority: Normal
NCT ID: NCT03077438 Org: User:
Start: 02/17/17 End: 10/10/17 Due: 10/10/18

Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India

Phase: N/A Priority: Normal
NCT ID: NCT02451358 Org: User:
Start: 07/27/15 End: 01/28/17 Due: 01/28/18

Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT00053508 Org: User:
Start: 09/30/02 End: 09/30/03 Due: 09/30/04

Trial to Describe the Safety and Immunogenicity of Fluzone®

Phase: N/A Priority: Normal
NCT ID: NCT00524940 Org: User:
Start: 08/31/07 End: 12/31/07 Due: 12/31/08

Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00415129 Org: User:
Start: 06/30/06 End: 03/31/09 Due: 03/31/10

Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00258830 Org: User:
Start: 09/30/05 End: 03/31/07 Due: 03/31/08

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01444352 Org: User:
Start: 06/30/10 End: 01/31/11 Due: 01/31/12

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02992418 Org: User:
Start: 12/19/16 End: 12/10/19 Due: 12/10/20

Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT06252285 Org: User:
Start: 02/06/24 End: 12/07/27 Due: 12/07/28

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Phase: N/A Priority: Normal
NCT ID: NCT00874549 Org: User:
Start: 10/31/07 End: 10/31/08 Due: 10/31/09

Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00831987 Org: User:
Start: 08/31/04 End: 02/28/06 Due: 02/28/07

Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children

Phase: N/A Priority: Normal
NCT ID: NCT01689155 Org: User:
Start: 06/30/11 End: 04/30/16 Due: 04/30/17